About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Not Yet RecruitingNANCT07480486

Pharmacogenetic-Guided Antidepressant Treatment in Depression

The purpose of this clinical trial is to evaluate whether using pharmacogenetic testing to guide antidepressant treatment can improve outcomes in adults with major depressive disorder in Morocco. Depr...

Lead sponsor: Mohammed V University in Rabat•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Meriem Atarki, PhD

CONTACT

+212687595174 meriem_atarki@um5.ac.ma

Sponsors

Lead Sponsor

Mohammed V University in Rabat

Collaborators

Ibn Sina University Hospital, Rabat, Morocco

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Diagnosis of a depressive disorder (major depressive disorder, depressive episode, or persistent depressive disorder) confirmed by a healthcare professional according to DSM-5 or ICD-10 criteria.
•Aged 18 years or older at the time of enrollment.
•Clinical indication for initiation or modification of antidepressant pharmacotherapy.
•Ability to understand study procedures and provide written informed consent.

Exclusion Criteria

•Inability to provide informed consent.
•Current acute psychotic disorder, manic episode, or uncontrolled bipolar disorder.
•Current pregnancy or breastfeeding.
•Use of medications with clinically significant interactions with antidepressants.
•Any severe medical condition that, in the opinion of the investigator, would compromise participant safety or study integrity.

Related studies

RECRUITINGPhase 3

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

NCT06793397 · Major Depressive Disorder (MDD), Depression in Adults, and more

Virtual Reality-Based Mindfulness as an Adjunct to Treatment as Usual in Treatment-Resistant Depression

NCT07422519 · Depression - Major Depressive Disorder, Depression Disorder, and more

Preliminary Efficacy Trial of a Digital Intervention for Depression and Cannabis Use

NCT06878859 · Depression - Major Depressive Disorder, Cannabis Use Disorder, and more

Fluoxetine on Emotional Experience (FLEX) Study

NCT07424781 · Depression - Major Depressive Disorder, Irritability, and more

Epigenetic Enhancement of Cognitive Training in Aging Mood Disorder Populations

NCT07404085 · Bipolar Disorder (BD), Depression - Major Depressive Disorder, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 9, 2026Terms

Trial snapshot

StatusNOT_YET_RECRUITING

PhaseNA

Enrollment570

Start dateApr 2026

Last updatedApr 9, 2026

Condition

Depression - Major Depressive Disorder

Locations shown

Ar-Razi Psychiatric Hospital, Ibn Sina University Hospital

Rabat, Rabat-Salé-Kénitra

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 9, 2026Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions